Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder
NCT ID: NCT00046384
Last Updated: 2013-11-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
INTERVENTIONAL
2002-06-30
2003-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
aripiprazole
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Local Institution
Scottsdale, Arizona, United States
Local Institution
Little Rock, Arkansas, United States
Local Institution
Chula Vista, California, United States
Local Institution
Pico Rivera, California, United States
Local Institution
Riverside, California, United States
Local Institution
San Diego, California, United States
Local Institution
Washington D.C., District of Columbia, United States
Local Institution
Winter Park, Florida, United States
Local Institution
Staten Island, New York, United States
Local Institution
Oklahoma City, Oklahoma, United States
Local Institution
Nashville, Tennessee, United States
Local Institution
Falls Church, Virginia, United States
Local Institution
Bellevue, Washington, United States
Local Institution
Mendoza, , Argentina
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CN138-077
Identifier Type: -
Identifier Source: org_study_id